The Industrial Phase-Transfer Catalysis Experts

PTC Tip of the Month E-Newsletter

PTC Catalyst of the Month - May 2023

Process to Produce Tetrabutylammonium Bromide

By Marc Halpern, the leading expert in industrial phase-transfer catalysis.

Tetrabutylammonium bromide (TBAB) is produced commercially in high yield by the straightforward reaction of tributylamine and butyl bromide when performed in the right solvent. From time to time, users of quaternary ammonium phase-transfer catalysts consider producing the quat salts themselves since the quaternization of the trialkylamine with an alkyl bromide or chloride is usually simple and reliable.

The challenge is obtaining the trialkylamine because not many producers are willing or have the capability to produce the trialkylamine that usually uses a toxic nickel catalyst. In the case of tributylamine, n-butyl alcohol and ammonia can react under the action of a catalyst to prepare tri-n-butylamine. According to the inventors of the patent CN116023269A (Shandong Tongcheng Medicine Co Ltd), the product of the method to produce tributylamine contains n-butylamine, di-n-butylamine and tri-n-butylamine, and the selectivity of the tri-n-butylamine is not as good as desired. If n-butyraldehyde and di-n-butylamine are adopted to react to generate enamine, and then reductive amination is carried out to obtain tri-n-butylamine, the problem of low selectivity of the tri-n-butylamine can be avoided, and the obtained product tri-n-butylamine has high yield and high purity.

The reductive amination is still not trivial to perform because it uses nickel tetracarbonyl as the catalyst, and hydrogen at 20-25 ATM (2.0-2.5 MPa). The solvent is toluene. The yield and selectivity are very good.

The abstract of the patent is as follows: “The invention discloses a synthesis method of tetrabutylammonium bromide, which takes n-butyraldehyde, di-n-butylamine and n-bromobutane as raw materials, hydrogen as a reducing agent and nickel tetracarbonyl as a catalyst, and sequentially performs serial reactions of enamine, reductive amination and quaternary amination, so that tetrabutylammonium bromide is generated by a one-pot method, the yield is 93-98%, and the product purity is 99.7-99.9%. The method has the advantages of convenient operation, simple raw materials and reagents, easy separation and purification of products and higher reaction yield.”


About Marc Halpern

Marc Halpern

Dr. Halpern is founder and president of PTC Organics, Inc., the only company dedicated exclusively to developing low-cost high-performance green chemistry processes for the manufacture of organic chemicals using Phase Transfer Catalysis. Dr. Halpern has innovated PTC breakthroughs for pharmaceuticals, agrochemicals, petrochemicals, monomers, polymers, flavors & fragrances, dyes & pigments and solvents. Dr. Halpern has provided PTC services on-site at more than 260 industrial process R&D departments in 37 countries and has helped chemical companies save > $200 million. Dr. Halpern co-authored five books including the best-selling “Phase-Transfer Catalysis: Fundamentals, Applications and Industrial Perspectives” and has presented the 2-day course “Practical Phase-Transfer Catalysis” at 50 locations in the US, Europe and Asia.

Dr. Halpern founded the journal “Industrial Phase-Transfer Catalysis” and “The PTC Tip of the Month” enjoyed by 2,100 qualified subscribers, now beyond 130 issues. In 2014, Dr. Halpern is celebrating his 30th year in the chemical industry, including serving as a process chemist at Dow Chemical, a supervisor of process chemistry at ICI, Director of R&D at Sybron Chemicals and founder and president of PTC Organics Inc. (15 years) and PTC Communications Inc. (20 years). Dr. Halpern also co-founded PTC Interface Inc. in 1989 and PTC Value Recovery Inc. in 1999. His academic breakthroughs include the PTC pKa Guidelines, the q-value for quat accessibility and he has achieved industrial PTC breakthroughs for a dozen strong base reactions as well as esterifications, transesterifications, epoxidations and chloromethylations plus contributed to more than 100 other industrial PTC process development projects.

Dr. Halpern has dedicated his adult life to his family and to phase-transfer catalysis (in that order!).

Leave a Reply

Your email address will not be published. Required fields are marked *

PTC Course - In-House

Learn to choose
PTC process conditions
LIKE AN EXPERT!

Learn More